Spectra Optia Apheresis System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Terumo BCT 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2015-09-01
  • 사례 출판 날짜
    2015-09-01
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: terumo bct spectra optia apheresis systems medical device manufacturer, terumo bct, has issued a medical device safety alert concerning its spectra optia apheresis systems. the manufacturer has received reports of data entry errors that cause the system to calculate a patient total blood volume (tbv) that is abnormal for that specific patient. the error can occur under the following circumstances:   the operator accidentally switches the values for height and weight when entering the data.   the patient is weighed and measured in units that are different from what the operator selects when entering the data.    the operator enters a height and a weight that are not accurate. if the operator does not enter correct data, the patient may receive excess anticoagulant (ac) or the outcome of the procedure may be affected. this issue can have the greatest effect on small or compromised patients for whom an abnormally high tbv calculation could lead to hypocalcemia. the manufacturer instructs affected users to review and confirm the data entered on the systems screens before connecting the patient to the system and throughout the procedure. the manufacturer will also provide software upgrade to mitigate the potential for data entry errors. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 1 september 2015.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Terumo BCT Spectra Optia Apheresis Systems
  • Manufacturer

Manufacturer